Table of Contents
Cough, Cold and Allergy (hay Fever) Remedies in Norway
Euromonitor
International
June 2009
List of Contents and Tables
Executive
Summary
OTC Healthcare Market Characterised by Preventative and Simple
Remedies
Marketing Plays Critical Role in Selling Products
Fragmentation Characterises Competitive Environment
Pharmacies Develop
Loyal and Satisfied Customer Base
Moderate Growth Predicted Over Forecast
Period
Key Trends and Developments
Brand Dynamics Become More
Important
Pharmacies Have Loyal and Satisfied Customers
Debate
Continues Regarding Price Sensitivity of OTC Healthcare Products
Norwegians More Open To Self-medication
Online Shopping on the Horizon
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical
Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market
Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table
4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC
Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand
Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution
Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and
Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC
Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC
Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC
Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins &
Dietary Supplements Registration and Classification
Self-medication and
Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare
Switches 2006-2008
Definitions
Summary 2 Research Sources
Axellus
As
Strategic Direction
Key Facts
Summary 3 Axellus AS : Key
Facts
Summary 4 Axellus AS: Operational Indicators
Company
Background
Production
Summary 5 Axellus AS: Production Statistics
2007
Competitive Positioning
Summary 6 Axellus AS: Competitive
Position 2008
Brynild Gruppen As
Strategic Direction
Key Facts
Summary 7 Brynild Gruppen AS: Key Facts
Summary 8 Brynild Gruppen AS:
Operational Indicators
Company Background
Production
Competitive
Positioning
Summary 9 Brynild Gruppen AS : Competitive Position 2008
Midelfart Sonesson As
Strategic Direction
Key Facts
Summary 10
Midelfart Sonesson AS: Key Facts
Summary 11 Midelfart Sonesson AS:
Operational Indicators
Company Background
Competitive Positioning
Summary 12 Midelfart Sonesson AS: Competitive Position 2008
Nycomed Pharma
As
Strategic Direction
Key Facts
Summary 13 Nycomed Pharma AS: Key
Facts
Summary 14 Nycomed Pharma AS: Operational Indicators
Company
Background
Production
Summary 15 Nycomed Pharma AS: Production
Statistics 2007
Competitive Positioning
Summary 16 Nycomed Pharma AS:
Competitive Position 2008
Weifa As
Strategic Direction
Key
Facts
Summary 17 Weifa AS: Key Facts
Summary 18 Weifa AS: Operational
Indicators
Company Background
Production
Summary 19 Weifa AS:
Production Statistics 2007
Competitive Positioning
Summary 20 Weifa
AS: Competitive Position 2008
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of
Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: %
Value Growth 2003-2008
Table 13 Sales of Decongestants by Type: Value
2003-2008
Table 14 Sales of Decongestants by Type: % Value Growth
2003-2008
Table 15 Herbal vs Standard Cough, Cold and Allergy (Hay Fever)
Remedies 2003-2008
Table 16 Cough, Cold and Allergy (Hay Fever) Remedies
Company Shares by Value 2004-2008
Table 17 Cough, Cold and Allergy (Hay
Fever) Remedies Brand Shares by Value 2005-2008
Table 18 Forecast Sales of
Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 19 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: % Value Growth 2008-2013
| 
View Cart
